NCT00320593

Brief Summary

The purpose of the study is to determine if progressive addition lenses (PALs) versus single vision lenses (SVLs) slow the progression of low myopia in children with poor accommodative responses (i.e., large accommodative lags) and near esophoria.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Apr 2005

Longer than P75 for phase_3

Geographic Reach
1 country

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2005

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 3, 2006

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

June 21, 2011

Completed
Last Updated

July 19, 2016

Status Verified

July 1, 2016

Enrollment Period

4.9 years

First QC Date

April 28, 2006

Results QC Date

May 17, 2011

Last Update Submit

July 15, 2016

Conditions

Keywords

MyopiaProgressive Addition Lenses (PALs)Single Vision Lenses (SVLs)Accommodative lagsNear esophoriaRefractive error

Outcome Measures

Primary Outcomes (2)

  • Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years

    Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is the sphere plus 1/2 the cylinder. For baseline and each time point, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

    Baseline to 3 years

  • Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years

    Measured in diopters (D) using cycloplegic refraction sphere (amount of myopia) and cylinder (amount of astigmatism at an angle (axis)). Spherical equivalent (SE) is defined as the sphere plus 1/2 the cylinder. For baseline and each time point, a SE was calculated for each eye for each of the five trials of cycloplegic autorefraction; the median for each eye was averaged to obtain the SE used for analysis. Change was calculated as SE at baseline minus SE at 3 years. A negative value indicates that the myopia worsened; a positive value indicates that it improved.

    3 years

Secondary Outcomes (7)

  • Distribution of Spherical Equivalent Refractive Error at 3 Years

    3 years

  • Mean Spherical Equivalent Refractive Error at 3 Years

    3 years

  • Distribution of Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics

    Baseline to 3 years

  • Mean Change in Spherical Equivalent Refractive Error From Baseline to 3 Years According to Baseline Characteristics

    Baseline to 3 years

  • Mean Change in Spherical Equivalent Refractive Error From Baseline to 1 Year

    Baseline to 1 year

  • +2 more secondary outcomes

Study Arms (2)

Progressive addition lenses (PALs)

ACTIVE COMPARATOR

Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition

Device: Progressive Addition Lenses (PALs)

Single vision lenses (SVLs)

ACTIVE COMPARATOR

Single vision lenses

Device: Single Vision Lenses (SVLs)

Interventions

Varilux Ellipse progressive addition lenses (PALs) with a +2.00 D addition

Progressive addition lenses (PALs)

Single vision lenses

Single vision lenses (SVLs)

Eligibility Criteria

Age8 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Refractive error determined by cycloplegic autorefraction which meets all of the following:
  • Spherical equivalent: -0.50 to -3.00 D in both eyes
  • Astigmatism \<= 1.5 D in both eyes
  • Anisometropia \<= 1.00 D difference between eyes in spherical equivalent
  • Visual acuity is at least 20/20 with best subjective refraction in both eyes
  • Accommodative response at near (33 cm) is less than 2.0D by non-cycloplegic autorefraction
  • Near esophoria (\>= 2.0 PD) present by alternate prism and cover test (APCT) at near using best refractive correction determined from non-cycloplegic subjective refraction

You may not qualify if:

  • Strabismus present by cover-uncover test at far, near, and/or near with +2.00D over best subjective refraction
  • Current or prior use of PALs, bifocals, or contact lenses in either eye (prior or current use of SVLs is allowed)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

University of Alabama- Birmingham, School of Optometry

Birmingham, Alabama, 35294, United States

Location

Southern California College of Optometry

Fullerton, California, 92831-1699, United States

Location

Indiana School of Optometry

Bloomington, Indiana, 47405, United States

Location

New England College of Optometry

Boston, Massachusetts, 02215-3468, United States

Location

Ohio State University College of Optometry

Columbus, Ohio, 43210-1280, United States

Location

Family Eye Group

Lancaster, Pennsylvania, 17601, United States

Location

Pennsylvania College of Optometry

Philadelphia, Pennsylvania, 19141, United States

Location

University of Houston College of Optometry

Houston, Texas, 77204-2020, United States

Location

Related Publications (3)

  • Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group; Manny RE, Chandler DL, Scheiman MM, Gwiazda JE, Cotter SA, Everett DF, Holmes JM, Hyman LG, Kulp MT, Lyon DW, Marsh-Tootle W, Matta N, Melia BM, Norton TT, Repka MX, Silbert DI, Weissberg EM. Accommodative lag by autorefraction and two dynamic retinoscopy methods. Optom Vis Sci. 2009 Mar;86(3):233-43. doi: 10.1097/OPX.0b013e318197180c.

  • Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group. Progressive-addition lenses versus single-vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria. Invest Ophthalmol Vis Sci. 2011 Apr 25;52(5):2749-57. doi: 10.1167/iovs.10-6631.

  • Lawrenson JG, Shah R, Huntjens B, Downie LE, Virgili G, Dhakal R, Verkicharla PK, Li D, Mavi S, Kernohan A, Li T, Walline JJ. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Feb 16;2(2):CD014758. doi: 10.1002/14651858.CD014758.pub2.

MeSH Terms

Conditions

MyopiaRefractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Limitations and Caveats

Limitations include: differential loss to follow up , differential compliance between the groups, power of near addition was not customized in PAL group, and we have no data on whether PAL group was looking through the near addition.

Results Point of Contact

Title
Raymond Kraker, MSPH
Organization
Jaeb Center for Health Research

Study Officials

  • Jane E Gwiazda, Ph.D.

    New England College of Optometry

    STUDY CHAIR
  • Wendy L Marsh-Tootle

    University of Alabama at Birmingham School of Optometry

    PRINCIPAL INVESTIGATOR
  • Ruth E Manny

    University of Houston College of Optometry

    PRINCIPAL INVESTIGATOR
  • Erik M Weissberg

    New England College of Optometry

    PRINCIPAL INVESTIGATOR
  • David I Silbert

    Family Eye Group

    PRINCIPAL INVESTIGATOR
  • Don W Lyon

    Indiana University

    PRINCIPAL INVESTIGATOR
  • Mitchell M Scheiman

    Pennsylvania College of Optometry

    PRINCIPAL INVESTIGATOR
  • Marjean T Kulp

    Ohio State University

    PRINCIPAL INVESTIGATOR
  • Susan A Cotter

    Southern California College of Optometry at Marshall B. Ketchum University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2006

First Posted

May 3, 2006

Study Start

April 1, 2005

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

July 19, 2016

Results First Posted

June 21, 2011

Record last verified: 2016-07

Locations